Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose
Data(s) |
2012
|
---|---|
Resumo |
Oral iron substitution has shown to be insufficient for treatment of severe iron deficiency anemia in pregnancy. Ferric carboxymaltose is a new intravenous (i.v.) iron formulation promising to be more effective and as safe as iron sucrose. We aimed to assess side effects and tolerance of ferric carboxymaltose compared to i.v. iron sucrose in pregnant women. |
Identificador |
http://boris.unibe.ch/16475/1/jpm-2011-0231.pdf Christoph, Patricia; Schuller, Christine; Studer, Hanna; Irion, Olivier; De Tejada, Begoña Martinez; Surbek, Daniel (2012). Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. Journal of perinatal medicine, 40(5), pp. 469-74. Berlin: De Gruyter 10.1515/jpm-2011-0231 <http://dx.doi.org/10.1515/jpm-2011-0231> doi:10.7892/boris.16475 info:doi:10.1515/jpm-2011-0231 info:pmid:22945271 urn:issn:0300-5577 |
Idioma(s) |
eng |
Publicador |
De Gruyter |
Relação |
http://boris.unibe.ch/16475/ |
Direitos |
info:eu-repo/semantics/openAccess |
Fonte |
Christoph, Patricia; Schuller, Christine; Studer, Hanna; Irion, Olivier; De Tejada, Begoña Martinez; Surbek, Daniel (2012). Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. Journal of perinatal medicine, 40(5), pp. 469-74. Berlin: De Gruyter 10.1515/jpm-2011-0231 <http://dx.doi.org/10.1515/jpm-2011-0231> |
Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion PeerReviewed |
Formato |
application/pdf |